US Anticoagulation Therapy Market is Determined to Cross US$ 27 Billion By 2024
New York, June 14, 2018: The scope of the report includes a detailed study of global and regional markets for US Anticoagulation Therapy Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report nature. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the global market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The US Anticoagulation Therapy Market is expected to exceed more than US$ 27 Billion by 2022 at a CAGR of...